Apolipoproteins, lipids and risk of cancer

被引:235
作者
Borgquist, Signe [1 ,2 ]
Butt, Talha [1 ]
Almgren, Peter [3 ,4 ]
Shiffman, Dov [5 ]
Stocks, Tanja [4 ,6 ]
Orho-Melander, Marju [4 ,6 ]
Manjer, Jonas [4 ,7 ]
Melander, Olle [3 ,4 ]
机构
[1] Lund Univ, Dept Clin Sci, Div Oncol & Pathol, SE-22185 Lund, Sweden
[2] Skane Univ Hosp, Dept Oncol, Lund, Sweden
[3] Lund Univ, Div Cardiol, Malmo, Sweden
[4] Lund Univ, Dept Clin Sci, Malmo, Sweden
[5] Quest Diagnost, Alameda, CA USA
[6] Lund Univ, Div Diabet & Cardiovasc Dis, Genet Epidemiol, Malmo, Sweden
[7] Lund Univ, Div Surg, Malmo, Sweden
基金
瑞典研究理事会;
关键词
apolipoproteins; obesity; cancer incidence; breast cancer; lung cancer; colorectal cancer; prostate cancer; DENSITY-LIPOPROTEIN CHOLESTEROL; CORONARY-HEART-DISEASE; BREAST-CANCER; PROSTATE-CANCER; ANTHROPOMETRIC FACTORS; OBESITY; ASSOCIATION; PREVENTION; PREDICTION; BIOMARKERS;
D O I
10.1002/ijc.30013
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
The epidemiological evidence for an obesity-cancer association is solid, whereas the association between obesity-associated lipoprotein levels and cancer is less evident. We investigated circulating levels of Apolipoprotein A1 (ApoA1), Apolipoprotein B (ApoB), LDL-cholesterol (LDL-C) and HDL-cholesterol (HDL-C) and association to risk of overall cancer and common cancer forms. The Malmo Diet and Cancer Study, a population-based prospective cohort study, enrolled 17,035 women and 11,063 men (1991-1996). Incident cancer cases were ascertained by record linkage with the Swedish Cancer Registry until end of follow-up, January 1, 2012. Baseline serum levels of ApoA1 and ApoB were analyzed for the entire cohort and HDL-C and LDL-C levels in 5,281 participants. Hazard ratios, with 95% confidence interval, were calculated using Cox's proportional hazards analysis. In the entire cohort, none of the exposures were related to overall cancer risk (HRadj ApoA1 = 0.98, 95% CI: 0.95,1.01; HRadj ApoB = 1.01, 95% CI: 0.98-1.04). Among men, ApoB was positively associated with cancer risk (HRadj ApoB = 1.06, 95% CI: 1.01,1.10). Female breast cancer risk was inversely associated with ApoB (HRadj = 0.92, 95% CI: 0.86,0.99). Among both genders, ApoA1 was inversely associated with lung cancer risk (HRadj = 0.88, 95% CI: 0.80,0.97), whereas high ApoB increased lung cancer risk (HRadj = 1.08, 95% CI: 0.99,1.18). Colorectal cancer risk was increased with high ApoB (HRadj = 1.08, 95% CI: 1.01,1.16) among both genders. Apolipoprotein levels were not associated with prostate cancer incidence. Circulating levels of apolipoproteins are associated with overall cancer risk in men and across both genders with breast, lung and colorectal cancer risk. Validation of these findings may facilitate future primary prevention strategies for cancer.
引用
收藏
页码:2648 / 2656
页数:9
相关论文
共 43 条
[1]
Prediagnostic Total and High-Density Lipoprotein Cholesterol and Risk of Cancer [J].
Ahn, Jiyoung ;
Lim, Unhee ;
Weinstein, Stephanie J. ;
Schatzkin, Arthur ;
Hayes, Richard B. ;
Virtamo, Jarmo ;
Albanes, Demetrius .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2009, 18 (11) :2814-2821
[2]
[Anonymous], 2013, AM SOC CLIN ONCOL ED
[4]
Anthropometric factors in relation to different tumor biological subgroups of postmenopausal breast cancer [J].
Borgquist, Signe ;
Jirstrom, Karin ;
Anagnostaki, Lola ;
Manjer, Jonas ;
Landberg, Goran .
INTERNATIONAL JOURNAL OF CANCER, 2009, 124 (02) :402-411
[5]
Applying What We Know to Accelerate Cancer Prevention [J].
Colditz, Graham A. ;
Wolin, Kathleen Y. ;
Gehlert, Sarah .
SCIENCE TRANSLATIONAL MEDICINE, 2012, 4 (127)
[6]
Preventing cancer, cardiovascular disease, and diabetes - A common agenda for the American Cancer Society, the American Diabetes Association, and the American Heart Association [J].
Eyre, H ;
Kahn, R ;
Robertson, RM ;
Clark, NG ;
Doyle, C ;
Hong, YL ;
Gansler, T ;
Glynn, T ;
Smith, RA ;
Taubert, K ;
Thun, MJ .
CIRCULATION, 2004, 109 (25) :3244-3255
[7]
Review of anthropometric factors and breast cancer risk [J].
Friedenreich, CM .
EUROPEAN JOURNAL OF CANCER PREVENTION, 2001, 10 (01) :15-32
[8]
RISK OF BREAST-CANCER IN RELATION TO BLOOD-LIPIDS - A PROSPECTIVE-STUDY OF 31,209 NORWEGIAN WOMEN [J].
GAARD, M ;
TRETLI, S ;
URDAL, P .
CANCER CAUSES & CONTROL, 1994, 5 (06) :501-509
[9]
Goff DC, 2014, CIRCULATION, V129, pS49, DOI [10.1161/01.cir.0000437741.48606.98, 10.1016/j.jacc.2013.11.005]
[10]
Metabolic complications of obesity [J].
Grundy, SM .
ENDOCRINE, 2000, 13 (02) :155-165